Role of lipoic acld in health and disease;Rola kwasu liponowego w zdrowiu i chorobie

Polski Merkuriusz Lekarski

Volumn 31, Issue 183, 2011, Pages 183-185

  Huk Kolega, Halina ^a   Skibska, Beata ^a   Kleniewska, Paulina ^a   Piechota, Aleksandra ^a   Michalski, Łukasz ^a   Gora̧ca, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidative activity; Lipoic acid; Therapeutic action

Indexed keywords

ANTIOXIDANT; CHELATING AGENT; HEAVY METAL; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

DIABETIC NEPHROPATHY; HUMAN; INTOXICATION; METABOLISM; MYCOSIS; REVIEW;

ANTIOXIDANTS; CHELATING AGENTS; DIABETIC NEPHROPATHIES; HUMANS; METALS, HEAVY; MYCOSES; POISONING; REACTIVE OXYGEN SPECIES; THIOCTIC ACID;

EID: 80053646670     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Bast A., Haenen G. R.: Lipoic acid: a multifunctional antioxidant. Biofactors, 2003;17(1-4);207-213. (Pubitemid 37267155)
2. Biewenga G., Haenen G., Bast A.: The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol., 1997;29(3);315-331.
3. Bilska A., Wlodek L.: Lipoic acid - the drug of future? Pharmacol. Rep, 2005;57(5);570-577.
4. Bitar M. S., Ayed A. K., Abdel-Halim S. M. et al.: Inflammation and apoptosis in aortic tissues: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism. Life Sci., 2010;86(23-24);844-853.
5. Butler J. A., Hagen T. M., Moreau R.: Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and down regulating liver triacylglycerol secretion. Arch. Biochem. Biophys., 2009;485(1);63-71.
6. Choi Y. H., Chai O. H., Han E. H. et al.: Lipoic acid suppresses compound 48/80-induced anaphylaxis-like reaction. Anat. Cell Biol., 2010;43(3);317-324.
7. Cremer D. R., Rabeler R., Roberts A. et al.: Long-term safety of a-lipoic acid (ALA) consumption: A 2-year study. Regul. Toxicol. Pharmacol., 2006;46(3);193-201. (Pubitemid 44692904)
8. Cremer D. R., Rabeler R., Roberts A. et al.: Safety evaluation of alphalipoic acid (ALA). Regul. Toxicol. Pharmacol., 2006;46(1);29-41. (Pubitemid 44293048)
9. Davi G., Santilli R, Patrono C: Neutraceuticals in diabetes and metabolic syndrome. Cardiovasc. Ther., 2010;28(4);216-226.
10. Di Stefano A., Sozio P., Cerasa L. S. et al.: Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model. Int. J. Immunopathol., 2010;23(2);589-599.
11. Flora S. J.: Structural, chemical and biological aspects of antioxidants for strategies against metal and metaloid exposure. Oxid. Med. Cell Longev., 2009;2(4);191-206.
12. Ghibu S., Richard C., Vergely C. et al.: Antioxidant properties of an endogenous thiol: alpha-lipoic acid used in the prevention of cardiovascular diseases. J. Cardiovasc. Pharmacol., 2009;54(3);391-398.
13. Goraca A., Aslanowicz-Antkowiak K.: Prophylaxis with alpha-lipoic acid against lipopolysaccharide-induced brain injury in rats. Arch. Immunol. Ther. Exp. (Warsz), 2009;57(2);141-146.
14. Gora̧ca A., Skibska B.: Beneficial effect of alpha-lipoic acid on lipopolysaccharide-induced oxidative stress in bronchoalveolar lavage fluid. J. Physiol. Pharmacol., 2008;59(2);379-386. (Pubitemid 351955759)
15. Heinisch B. B., Francesconi M., Mittermayer F. et al.: Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebocontrolled randomized trial. Eur. J. Clin. Invest., 2010;40(2);148-154.
16. Kanter M., Sen S., Donmez S. et al.: Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats. Ren. Fail., 2010;32(4);498-505.
17. Kiemer A. K., Muller C., Vollmar A. M.: Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol. Cell Biol., 2002;80(6);550-557. (Pubitemid 35335018)
18. Kim M. S., Park J. Y., Namkoong C. et al.: Anti-obesity effects of lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med., 2004;10(7);727-733. (Pubitemid 38937638)
19. Kim H. Y., Or. Y., Kim M. et al.: Protective effect of lipoic acid against mythylglyoxal-induced oxidative stress in LLC-PK1 cells. J. Nutr. Sci. Vitaminol., 2008;54;99-104. (Pubitemid 351413110)
20. Koh E. H., Lee W. J., Lee S. A. et al.: Effects of alpha-lipoic acid on body weight in obese subjects. Am. J. Med., 2011;124(1);85.e 1-8.
21. Lee W. J., Song K. H., Koh E. H. et al.: Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun., 2005;8;332(3);885-891.
22. Lee W. Y., Orestes P., Latham J. et al.: Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J. Neurosci., 2009;29(30);9500-9509.
23. Maczurek A., Hager K., Kenklies M. et al.: Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv. Drug Delivery Rev., 2008;60(13-14);1463-1470.
24. Malinska D., Winiarska K.: Lipoic acid: characteristics and therapeutic applications. Post Hig. Med. Dosw., 2005;59;535-543.
25. Mijnhout G. S., Alkhalaf A., Kleefstra N. et al.: Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes. Neth. J. Med., 2010;68(4);158-162.
26. Nickander K. K., McPhee B. R., Low P. A. et al.: Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic. Biol. Med., 1996;21(5);631-639. (Pubitemid 26331093)
27. Odabasoglu F., Halici Z., Aygun H. et al.: α-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br. J. Nutr., 2011;105(1);31-43.
28. Packer L., Tritschler H. J., Wessel K.: Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med., 1997;22(1-2);359-378.
29. Packer L., Witt E. H., Tritschler H. J.: Alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 1995;19(2);227-250.
30. Packer L., Kraemer K., Rimbach G.: Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 2001;17(10);888-895. (Pubitemid 33001657)
31. Palacka P., Kucharska J., Murin J. et al.: Complementary therapy in diabetic patients with chronic complications; a pilot study. Brat. Lek. Listy, 2010;111(4);205-211.
32. Piechota A., Gora̧ca A.: The comparison of alpha-lipoic acid, melatonin, vitamin C and trolox effectiveness in decreasing DNA stand brakes and increasing plasma antioxidant power. Pol. Merk. Lek., 2009;27(157);19-21.
33. Prieto-Hontoria P. L., Pérez-Matute P., Femández-Galilea M. et al.: Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol. Nutr. Food Res., 2011, doi:10.1002/mnfr.201000534 [w druku].
34. Reed L. J., De Busk B. G., Gansalusic I. C. et al.: Crystalline a-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science, 1951;114(2952);93-94.
35. Reed L. J.: From lipoic acid to multi-enzyme complex. Protein Sci., 1998;7(1);220-224.
36. Schupke H., Hempel R., Peter G. et al.: New metabolic pathways of alpha-lipoic acid. Drug Metab. Dispos., 2001;29(6);855-862. (Pubitemid 32488642)
37. Scott B. C., Aruoma O. I., Evans P. J. et al.: Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res., 1994;20(2);119-133. (Pubitemid 24103740)
38. Sen C. K., Packer L.: Antioxidant and redox regulation of gene transcription. FASEB J., 1996;10(7);709-720. (Pubitemid 26172817)
39. Shay K. P., Moreau R. F., Smith E. J. et al.: Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta, 2009;1790(10);1149-1160.
40. Singh U., Jialal I.: Alpha-lipoic acid supplementation and diabetes. Nutr. Rev., 2008;66(11);646-657.
41. Streeper R. S., Henriksen E. J., Jacob S. et al.: Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am. J. Physiol., 1997;273(1 Pt 1);E185-E191.
42. Strosznajder J. B., Mossakowski M. J.: Mózg a starzenie siȩ. Polska Akademia Nauk, Centrum Upowszechniania Nauki, Warszawa 2001;171-185.
43. Suh J. H., Shenvi S. V., Dixon B. M. et al.: Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci., USA, 2004;101(10);3381- 3386. (Pubitemid 38338203)
44. Suzuki Y. J., Tsuchiya M., Packer L.: Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic. Res. Commun., 1993;18(2);115-122. (Pubitemid 23173513)
45. Winkler G., Kempler P.: Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy. Orv. Hetil., 2010;151(24);971-981.
46. Wollen K. A.: Alzheimer Disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altera Med. Rev., 2010;15(3);223-244.
47. Wollin S. D., Jones P. J.: Alpha-lipoic acid and cardiovascular disease. J. Nutr., 2003;133(11);3327-3330.